Andre Moa

Recent Posts

2019 New Drug Approvals And Updates: The Year In Review

Posted by Andre Moa on Dec 6, 2019 12:24:26 PM

Launch excellence for pharmaceuticals depends on a multitude of factors, from pricing, reimbursement and health technology assessment (HTA) to positioning, sequencing, sales, marketing, media coverage and the competitive landscape. None of these can get off the ground, though, without regulatory approvals in key markets. Here, we tally up 2019 new drug approvals to date in the US and the European Union.


Read More

Topics: launch readiness

How digital transformation can streamline your new pharma product launch

Posted by Andre Moa on Nov 5, 2019 2:47:15 PM

Digital technology and media have disrupted and revolutionised pharmaceuticals from research to market entry and beyond. That presents some challenges to product launches but also opportunities to maximise launch efficiency. In an ever more global, complex and volatile market environment, digital transformation of a traditionally conservative industry creates fresh possibilities to bring both launch strategy and execution into alignment.  

Read More

Topics: launch readiness

How to keep your global and country launch team aligned

Posted by Andre Moa on May 30, 2019 10:38:00 AM

When a new drug comes to market, chances are it will launch globally, or at least across multiple territories. It’s a global marketplace, and with all the restraints on pharmaceutical growth these days, you’ll want to spread your bets. Your launch team needs to be organised globally too.

Read More

Topics: launch readiness

How to ensure efficient launch collaboration in a cross-functional team

Posted by Andre Moa on Apr 30, 2019 11:00:00 AM



A pharmaceutical new product launch demands a high level of collaboration by a cross-functional team in what is often a siloed and geographically dispersed business.

Read More

The Ultimate Guide to Launch Readiness in 2019

Posted by Andre Moa on Feb 5, 2019 7:45:00 AM

Pharmaceutical companies have more reasons than ever to hone their launch readiness skills. The question is whether they possess the new product launch strategies and tools to successfully commercialise their new medicines in an often volatile and always competitive global marketplace.  

Read More

Topics: launch readiness, launch strategy, launch effectiveness, launch readiness framework, launch plan, pharma tenders